{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:00:16Z","timestamp":1771826416312,"version":"3.50.1"},"reference-count":49,"publisher":"Jaypee Brothers Medical Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.59556\/japi.74.1297","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:06:21Z","timestamp":1771823181000},"page":"27-31","source":"Crossref","is-referenced-by-count":0,"title":["Real-world Utilization of Mineralocorticoid Receptor Antagonists in India and the Benefits of GDMT in Heart Failure"],"prefix":"10.59556","volume":"74","author":[{"given":"Nilesh","family":"Gautam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parijat D","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Batta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev K","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant","family":"Kannodia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K Krishna","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Munichoodappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaustubh","family":"Durve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vamsie","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Febin","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarnath","family":"Sugumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthilnathan","family":"Mohanasundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(3):","key":"key20260223050615_B1","first-page":"196\u2013","article-title":"Foundation four therapy in heart failure: a real-world experience from a cardiac clinic in India.","volume":"5","author":"Pitchai","year":"2023;","journal-title":"Int J Dent Med Sci Res"},{"issue":"(18):","key":"key20260223050615_B2","doi-asserted-by":"crossref","first-page":"1835\u2013","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction.","volume":"81","author":"Kittleson","year":"2023;","journal-title":"JACC"},{"issue":"(18):","key":"key20260223050615_B3","first-page":"e895\u2013","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"145","author":"Heidenreich","year":"2022;","journal-title":"Circulation"},{"issue":"(8):","key":"key20260223050615_B4","first-page":"11\u2013","article-title":"Heart failure with preserved ejection fraction: management guidelines (from Heart Failure Association of India, endorsed by Association of Physicians of India). J","volume":"70","author":"Harikrishnan","year":"2022;","journal-title":"Assoc Physicians India"},{"issue":"(2):","key":"key20260223050615_B5","first-page":"148\u2013","article-title":"2024 guidelines of the Taiwan Society of Cardiology for the diagnosis and treatment of heart failure with preserved ejection fraction.","volume":"40","author":"Li","year":"2024;","journal-title":"Acta Cardiol Sin"},{"issue":"(3):","key":"key20260223050615_B6","doi-asserted-by":"crossref","first-page":"133\u2013","DOI":"10.4103\/jpcs.jpcs_1_18","article-title":"Heart Failure Guidelines for India: update 2017.","volume":"3","author":"Seth","year":"2017;","journal-title":"J Pract Cardiovasc Sci"},{"issue":"(2):","key":"key20260223050615_B7","doi-asserted-by":"crossref","first-page":"243\u2013","DOI":"10.1007\/s40119-024-00367-4","article-title":"Management of heart failure in a resource-limited setting: expert opinion from India.","volume":"13","author":"Jain","year":"2024;","journal-title":"Cardiol Ther"},{"key":"key20260223050615_B8","unstructured":"Borlaung BA, Colucci WS. Treatment and Prognosis of Heart Failure with Preserved Ejection Fraction [Internet]. UpToDate. 2023 [cited 2023 Sep 27]. Available from: https:\/\/www.uptodate.com\/contents\/treatment-and-prognosis-of-heart-failure-with-preserved-ejection-fraction\/print#:~:text=Goals%20of%20therapy%20%E2%80%94%20For%20patients,the%20risk%20of%20hospital%20admission."},{"issue":"(1):","key":"key20260223050615_B9","first-page":"4\u2013","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.","volume":"24","author":"McDonagh","year":"2022;","journal-title":"Eur J Heart Fail"},{"issue":"(Suppl 1):","key":"key20260223050615_B10","doi-asserted-by":"crossref","first-page":"S1\u2013","DOI":"10.1016\/j.ihj.2018.05.003","article-title":"CSI position statement on management of heart failure in India.","volume":"70","author":"Guha","year":"2018;","journal-title":"Indian Heart J"},{"issue":"(3):","key":"key20260223050615_B11","doi-asserted-by":"crossref","first-page":"e002493.","DOI":"10.1161\/JAHA.115.002493","article-title":"Barriers to adoption of mineralocorticoid receptor antagonists in patients with heart failure: a mixed-methods study.","volume":"5","author":"Dev","year":"2016;","journal-title":"J Am Heart Assoc"},{"issue":"(1):","key":"key20260223050615_B12","doi-asserted-by":"crossref","first-page":"74.","DOI":"10.5334\/gh.1355","article-title":"Use of guideline-recommended heart failure drugs in high-, middle-, and low-income countries: a systematic review and meta-analysis.","volume":"19","author":"Satheesh","year":"2024;","journal-title":"Glob Heart"},{"issue":"(10):","key":"key20260223050615_B13","doi-asserted-by":"crossref","first-page":"709\u2013","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999;","journal-title":"N Engl J Med"},{"issue":"(14):","key":"key20260223050615_B14","doi-asserted-by":"crossref","first-page":"1309\u2013","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003;","journal-title":"N Engl J Med"},{"issue":"(1):","key":"key20260223050615_B15","doi-asserted-by":"crossref","first-page":"11\u2013","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms.","volume":"364","author":"Zannad","year":"2011;","journal-title":"N Engl J Med"},{"issue":"(10458):","key":"key20260223050615_B16","doi-asserted-by":"crossref","first-page":"1119\u2013","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.","volume":"404","author":"Jhund","year":"2024;","journal-title":"Lancet"},{"key":"key20260223050615_B17","doi-asserted-by":"crossref","first-page":"101556.","DOI":"10.1016\/j.cegh.2024.101556","article-title":"Unveiling the impact of an Indian-specific heart failure checklist on heart failure with reduced ejection fraction management in the South Indian population.","volume":"27:","author":"Philip","year":"2024;","journal-title":"Clin Epidemiol Glob Health"},{"issue":"(8):","key":"key20260223050615_B18","doi-asserted-by":"crossref","first-page":"794\u2013","DOI":"10.1002\/ejhf.283","article-title":"Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry.","volume":"17","author":"Harikrishnan","year":"2015;","journal-title":"Eur J Heart Fail"},{"issue":"(9):","key":"key20260223050615_B19","first-page":"908\u2013","article-title":"The Cardiology Society of India-Kerala acute heart failure registry: poor adherence to guideline-directed medical therapy.","volume":"43","author":"Joseph","year":"2021;","journal-title":"Eur Heart J"},{"key":"key20260223050615_B20","doi-asserted-by":"crossref","first-page":"139\u2013","DOI":"10.1016\/j.ijcard.2020.10.012","article-title":"Five-year mortality and readmission rates in patients with heart failure in India: results from the Trivandrum heart failure registry.","volume":"326:","author":"Harikrishnan","year":"2021;","journal-title":"Int J Cardiol"},{"issue":"(8):","key":"key20260223050615_B21","doi-asserted-by":"crossref","first-page":"3225\u2013","DOI":"10.4103\/jfmpc.jfmpc_1868_23","article-title":"Clinical profile, treatment patterns and one-year outcome of heart failure patients admitted in tertiary care hospital of North India.","volume":"13","author":"Shah","year":"2024;","journal-title":"J Family Med Prim Care"},{"issue":"(3):","key":"key20260223050615_B22","doi-asserted-by":"crossref","first-page":"147\u2013","DOI":"10.1016\/j.ihj.2024.04.004","article-title":"Heart failure, the global pandemic: a call to action consensus statement from the global presidential conclave at the platinum jubilee conference of cardiological society of India 2023.","volume":"76","author":"Harikrishnan","year":"2024;","journal-title":"Indian Heart J"},{"issue":"(10367):","key":"key20260223050615_B23","doi-asserted-by":"crossref","first-page":"1938\u2013","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.","volume":"400","author":"Mebazaa","year":"2022;","journal-title":"Lancet"},{"issue":"(6):","key":"key20260223050615_B24","doi-asserted-by":"crossref","first-page":"3898\u2013","DOI":"10.1002\/ehf2.14096","article-title":"Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure Registry.","volume":"9","author":"Harikrishnan","year":"2022;","journal-title":"ESC Heart Fail"},{"key":"key20260223050615_B25","doi-asserted-by":"crossref","first-page":"73\u2013","DOI":"10.1016\/j.ijcard.2022.03.021","article-title":"Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR).","volume":"356:","author":"Jayagopal","year":"2022;","journal-title":"Int J Cardiol"},{"key":"key20260223050615_B26","doi-asserted-by":"crossref","first-page":"133\u2013","DOI":"10.1016\/j.ijcard.2015.11.183","article-title":"Heart failure in Africa, Asia, the Middle East and South America: the INTER-CHF study.","volume":"204:","author":"Dokainish","year":"2016;","journal-title":"Int J Cardiol"},{"issue":"(7):","key":"key20260223050615_B27","doi-asserted-by":"crossref","first-page":"e665\u2013","DOI":"10.1016\/S2214-109X(17)30196-1","article-title":"Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study.","volume":"5","author":"Dokainish","year":"2017;","journal-title":"Lancet Glob Health"},{"issue":"(9):","key":"key20260223050615_B28","doi-asserted-by":"crossref","first-page":"e1008\u2013","DOI":"10.1016\/S2214-109X(18)30306-1","article-title":"Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.","volume":"6","author":"Teng","year":"2018;","journal-title":"Lancet Glob Health"},{"issue":"(8):","key":"key20260223050615_B29","doi-asserted-by":"crossref","first-page":"e1001699.","DOI":"10.1371\/journal.pmed.1001699","article-title":"Heart failure care in low- and middle-income countries: a systematic review and meta-analysis.","volume":"11","author":"Callender","year":"2014;","journal-title":"PLoS Med"},{"issue":"(15):","key":"key20260223050615_B30","doi-asserted-by":"crossref","first-page":"1658\u2013","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure.","volume":"302","author":"Albert","year":"2009;","journal-title":"JAMA"},{"issue":"(1):","key":"key20260223050615_B31","doi-asserted-by":"crossref","first-page":"39\u2013","DOI":"10.1161\/CIRCULATIONAHA.104.527549","article-title":"Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001.","volume":"112","author":"Masoudi","year":"2005;","journal-title":"Circulation"},{"issue":"(12):","key":"key20260223050615_B32","doi-asserted-by":"crossref","first-page":"e002268.","DOI":"10.1161\/JAHA.115.002268","article-title":"Temporal trends and hospital variation in mineralocorticoid receptor antagonist use in veterans discharged with heart failure.","volume":"4","author":"Dev","year":"2015;","journal-title":"J Am Heart Assoc"},{"key":"key20260223050615_B33","unstructured":"Government of India. Indian National List of Essential Medicines (NLEM): Drugs (Prices Control) Amendment Order, 2022 [Internet]. Ministry of Health & Family Welfare and Ministry of Chemical and Fertilizers; 2022. Available from: https:\/\/thehealthmaster.com\/wp-content\/uploads\/2022\/11\/S.O.-5249E-dt-11-11-2022-National-List-of-Essential-Medicines-2022-EC-Act-1955.pdf."},{"key":"key20260223050615_B34","doi-asserted-by":"crossref","unstructured":"Manikandan S. The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line. The Lancet Regional Health\u2014Southeast Asia [Internet]; 2023 [cited 2025 Mar 24]. Available from: https:\/\/www.thelancet.com\/journals\/lansea\/article\/PIIS2772-3682(23)00062-8\/fulltext.","DOI":"10.1016\/j.lansea.2023.100202"},{"issue":"(1):","key":"key20260223050615_B35","first-page":"21\u2013","article-title":"Enhancing heart failure care in India: the critical role of generic drugs and regulatory reforms.","volume":"2","author":"Salam","year":"2024;","journal-title":"Heart Fail J India"},{"issue":"(4):","key":"key20260223050615_B36","first-page":"e008971.","article-title":"Access to heart failure medicines in low- and middle-income countries: an analysis of essential medicines lists, availability, price, and affordability.","volume":"15","author":"Agarwal","year":"2022;","journal-title":"Circ Heart Fail"},{"issue":"(5):","key":"key20260223050615_B37","doi-asserted-by":"crossref","first-page":"612\u2013","DOI":"10.18203\/2319-2003.ijbcp20242417","article-title":"Cost analysis of drugs used in management of heart failure with reduced ejection fraction and marketed in India.","volume":"13","author":"Tupe","year":"2024;","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"(1):","key":"key20260223050615_B38","doi-asserted-by":"crossref","first-page":"69.","DOI":"10.5334\/gh.1348","article-title":"Heart failure with reduced ejection fraction polypill implementation strategy in India: a convergent parallel mixed methods study.","volume":"19","author":"Agarwal","year":"2024;","journal-title":"Glob Heart"},{"issue":"(5):","key":"key20260223050615_B39","doi-asserted-by":"crossref","first-page":"845\u2013","DOI":"10.1016\/j.jacc.2005.06.010","article-title":"The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.","volume":"46","author":"Shah","year":"2005;","journal-title":"J Am Coll Cardiol"},{"issue":"(9):","key":"key20260223050615_B40","first-page":"e45241.","article-title":"Impact of mineralocorticoid receptor antagonists in the treatment of heart failure: targeting the heart failure cascade.","volume":"15","author":"Jadhav","year":"2023;","journal-title":"Cureus"},{"issue":"(1):","key":"key20260223050615_B41","doi-asserted-by":"crossref","first-page":"4.","DOI":"10.1007\/s11892-019-1123-8","article-title":"Mineralocorticoid antagonism and diabetic kidney disease.","volume":"19","author":"Lytvyn","year":"2019;","journal-title":"Curr Diab Rep"},{"key":"key20260223050615_B42","first-page":"6\u2013","article-title":"Mineralocorticoid receptor antagonist in heart failure: past, present and future perspectives.","volume":"3:","author":"Vizzardi","year":"2014;","journal-title":"Int J Cardiol Heart Vessel"},{"issue":"(37):","key":"key20260223050615_B43","doi-asserted-by":"crossref","first-page":"3627\u2013","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"44","author":"McDonagh","year":"2023;","journal-title":"Eur Heart J"},{"issue":"(5):","key":"key20260223050615_B44","doi-asserted-by":"crossref","first-page":"455\u2013","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.","volume":"37","author":"Solomon","year":"2016;","journal-title":"Eur Heart J"},{"issue":"(9):","key":"key20260223050615_B45","doi-asserted-by":"crossref","first-page":"1326\u2013","DOI":"10.1002\/ejhf.1182","article-title":"Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry.","volume":"20","author":"Savarese","year":"2018;","journal-title":"Eur J Heart Fail"},{"issue":"(10):","key":"key20260223050615_B46","doi-asserted-by":"crossref","first-page":"1284\u2013","DOI":"10.1002\/ejhf.900","article-title":"Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF.","volume":"19","author":"Ferreira","year":"2017;","journal-title":"Eur J Heart Fail"},{"issue":"(4S):","key":"key20260223050615_B47","doi-asserted-by":"crossref","first-page":"S117\u2013","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease.","volume":"105","author":"Stevens","year":"2024;","journal-title":"Kidney Int"},{"issue":"(6):","key":"key20260223050615_B48","doi-asserted-by":"crossref","first-page":"e002606.","DOI":"10.1161\/JAHA.115.002606","article-title":"Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials.","volume":"5","author":"Ruppar","year":"2016;","journal-title":"J Am Heart Assoc"},{"issue":"(5):","key":"key20260223050615_B49","doi-asserted-by":"crossref","first-page":"93\u2013","DOI":"10.1007\/s11936-023-00979-4","article-title":"Novel strategies to improve prescription of guideline-directed medical therapy in heart failure.","volume":"25","author":"Brooksbank","year":"2023;","journal-title":"Curr Treat Options Cardio Med"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:06:28Z","timestamp":1771823188000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-1-s1-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.59556\/japi.74.1297"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1297","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}